Fierce Biotech July 21, 2022
Sponsored by PathAI

Mike Montalto, Chief Scientific Officer at PathAI , sat down with Joseph Szustakowski, VP of Translational Bioinformatics at Bristol Myers Squibb [BMS], to discuss AI-powered digital pathology. Learn how BMS is unlocking new insights in translational research and development by injecting innovative computational AI-based approaches into the traditional field of pathology.

MM: Hi Joe, thanks for taking the time today to discuss recent innovation and approaches in AI-powered digital pathology, especially in the context of your experience at Bristol Myers Squibb. To start, can you talk about your role at BMS, the role of your organization, and how digital pathology fits into that organization?

JS: Sure, I lead a computational research organization that’s called Translational Bioinformatics. We are a team...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Conferences / Podcast, Pharma / Biotech, Technology, Trends
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Google DeepMind unveils ‘superhuman’ AI system that excels in fact-checking, saving costs and improving accuracy
Katie Couric Talks Colon Cancer, Health Equity And AI
5 tips on AI adoption from a frontline physician champion
Survey of Oncologists Finds Agreement, Concerns Over AI Use

Share This Article